Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for Right Heart Failure after Valve Replacement
NCT02644616Phase 4Completed
- Sponsor
- Shanghai Chest Hospital
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in right-sided heart failure, tricuspid regurgitation, sponsored by Shanghai Chest Hospital. Started Nov 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
right-sided heart failuretricuspid regurgitation
Beyond the preview
Go deeper on NCT02644616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644616.